Saturday, March 28, 2015 7:46:33 AM
http://www.businesswire.com/news/home/20120618005809/en/KineMed-Announces-Biomarker-Discovery-Collaboration-GSK#.VRaUd_nF_kM
Kinemed Biomarker deal with ISIS pharmaceuticals
http://chdifoundation.org/huntingtons-disease-therapeutic-and-companion-biomarker-collaboration-forged-by-kinemed-isis-pharmaceuticals-and-chdi-foundation-2/
Ravi Kiron is well connected individual who held senior management positions with Pfizer and J&J.
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM